Our data showed that STAG2 knockdown not only made BRAF-mutant thyroid cancer cells more dependent on glutamine rather than glucose, but also rendered them more sensitive to glutaminase inhibitor. The gene discussed is GLS; the disease is thyroid gland carcinoma.